| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |